The New Law on Private Investigations: Challenges, Risks, and Best Practices
Webinar | 01.28.25, 12:00 PM CET - 2:00 PM CET
Address
Virtual
In collaboration with the IBJ
The Belgian law of 18 May 2024 regulating private investigations marks a significant shift in the legal landscape for employers conducting internal investigations. This comprehensive reform replaces outdated legislation and introduces stricter compliance requirements, notably impacting data privacy and HR practices. Understanding these legal requirements is essential to avoid potential pitfalls and ensure that investigations are carried out in a lawful and efficient manner.
On Tuesday, January 28 at 12:00 CET, Crowell & Moring will host a webinar to help employers, HR professionals, and legal practitioners navigate the new regulatory framework, mitigate risks, and adopt best practices.
This webinar will cover:
- How does the new law on private investigations impact internal investigations and litigation?
- The general principles and structure of the new legal framework
- HR law aspects: key considerations for employers
- Certification requirements for private investigators
- GDPR implications and interactions with the EU Whistleblower Directive
- Practical recommendations for implementing internal policies
For more information, please visit these areas: Corporate and Commercial — Brussels Practice, Corporate — Brussels Practice, Dispute Resolution — Brussels Practice, Labor and Employment — Brussels Practice, Dispute Resolution — Brussels Practice/IP, Intellectual Property — Brussels Practice, Regulatory — Brussels Practice, Technology, Media, and Telecommunications — Brussels Practice, Privacy and Cybersecurity — Brussels Practice
Participants
Insights
Webinar | 02.25.25
First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era
Please join us for a post-Election webinar with the heads of our Government Affairs group who will address the myriad of areas in the Life Sciences industry that will likely be impacted by the new administration, including FDA, NIH, drug pricing, imports, and exports.
Webinar | 02.20.25
